New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
10:08 EDTRAD, WAG, CVSRite Aid free-cash-flow, multiple make attractive M&A candidate, Bloomberg says
Rite Aid's (RAD) turnaround progress, high free-cash-flow yield and profit multiple make it a potentially attractive takeover candidate for bigger peers CVS (CVS) and Walgreen (WAG), according to analysts at BTIG and BB&T, said Bloomberg's "Real M&A" column. Reference Link
News For RAD;WAG;CVS From The Last 14 Days
Check below for free stories on RAD;WAG;CVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
12:03 EDTWAGStocks with call strike movement; AAPL WAG
Subscribe for More Information
08:32 EDTRADRite Aid reports July SSS up 4.6%
Subscribe for More Information
08:25 EDTCVSCVS Caremark earns first Community Pharmacy accreditation from URAC
Subscribe for More Information
July 30, 2014
09:00 EDTCVSMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. “We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” said Paul Julian, executive vice president, group president, McKesson Corporation. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
July 29, 2014
07:55 EDTCVSLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
July 28, 2014
12:21 EDTCVSOn The Fly: Midday Wrap
Subscribe for More Information
09:17 EDTCVSOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTCVSHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information
July 25, 2014
13:13 EDTRADEinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
July 24, 2014
16:09 EDTRADRite Aid names Darren Karst as executive VP, CFO
Subscribe for More Information
16:05 EDTRADRoundy's CFO Karst leaves for Rite-Aid, names Michael Turzenski as CFO
Roundy’s (RNDY) announced that Darren Karst, Roundy’s executive VP and CFO will be leaving the company to join Rite Aid (RAD) as its executive VP and CFO. Karst will remain with Roundy’s through August 9. Michael Turzenski, currently Roundy’s group VP and Chief Accounting Officer, has been appointed group VP, CFO by Roundy’s board. Turzenski has served as group VP, Chief Accounting Officer since February 2012. Turzenski joined Roundy’s in 2007 as VP, controller.
09:17 EDTWAGWalgreen's president of pharmacy, health and wellness announces retirement
Subscribe for More Information
July 23, 2014
06:02 EDTWAGWalgreen implied volatility of 37 at upper end of index mean range
July 22, 2014
10:07 EDTWAGWalgreen new corporate structure could add $10-$12 upside, says Deutsche Bank
Subscribe for More Information
09:51 EDTWAGWalgreen added to short-term buy list at Deutsche Bank
July 18, 2014
06:21 EDTWAGCTW Investment asks SEC to probe Walgreen's meetings, NY Post says
CTW Investment Group has asked the SEC to investigate private meetings that top Walgreen (WAG) executives held with investors to reincorporate overseas for tax reasons, reports the New york Post. The pension advisor is raising questions about whether Walgreen's meetings with Goldman Sachs (GS), Jana Partners, Och-Ziff and Corvex broke fair disclosure rules. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use